Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.35
-
NAV
₹15.56
-
Fund Started
18 Oct 2021
-
Fund Size
₹210.46 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year
3.52%
-
3 Year
20.71%
-
5 Year
-
-
Equity
98.24%
-
Cash
1.76%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.76% |
Divi's Laboratories Ltd. | 8.96% |
Apollo Hospitals Enterprise Ltd. | 6.21% |
Max Healthcare Institute Ltd. | 5.49% |
Torrent Pharmaceuticals Ltd. | 4.98% |
Aurobindo Pharma Ltd. | 4.55% |
Lupin Ltd. | 3.69% |
Fortis Healthcare Ltd. | 3.66% |
Alkem Laboratories Ltd. | 3.36% |
Aster DM Healthcare Ltd. | 2.81% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
